Skip to main content
. 2023 Nov 2;20(12):6213–6225. doi: 10.1021/acs.molpharmaceut.3c00626

Table 6. PK Model-Informed Release Rates and Total Fraction Dose Releaseabcde.

      systemic elimination SC depot release via direct process
SC depot release via indirect process
 
formulation species dose kelimination (h–1) kdirect (h–1) t1/2 (days)b Fracdirect kindirect (h–1) t1/2 (days)b Tlag/MTT (days) Fracindirect F%c
aqueous suspension (100 mg/mL) rat 10 mg/kg 0.016 0.018 1.6 0.09 0.00309 9.3 6.5d 0.91 136
dog 6 mg/kg 0.023 0.0065 4.4 0.13 0.00326 8.8 0.6d 0.87 92
  human 30–450 mg 0.003 0.007 4.1 0.14 0.000623 46.3 0.3d 0.86 112
PEG/water solution (309 mg/mL) rat 50 mg/kg 0.016 0.069 0.4 0.02 0.000818 35.3 15e 0.98 75
dog 12 mg/kg 0.023 0.014 2.1 0.06 0.0015 19.2 7.3e 0.94 80
a

Parameter definition shown in Scheme 2; kelimination = 0.693/terminal t1/2 from IV PK.

b

t1/2 = 0.693/kdirect or indirect.

c

Model-estimated total fraction release.

d

Tlag.

e

MTT, given by MTT = (no. of transit compartments + 1)/ktr.